Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation

被引:34
|
作者
Galindo, MF
Jordán, J
González-García, C
Ceña, V
机构
[1] Univ Castilla La Mancha, Ctr Reg Invest Biomed, Fac Med, Albacete 02071, Spain
[2] Univ Castilla La Mancha, Dpto Ciencias Med, Fac Med, Albacete 02071, Spain
关键词
apoptosis; cell death; mitochondria; neurodegeneration; oxidative stress; reactive oxygen species;
D O I
10.1046/j.1471-4159.2003.01592.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our results provide evidence that 6-hydroxydopamine induced, after auto-oxidation, toxic levels of hydrogen peroxide (H2O2) that caused bovine chromaffin cell toxicity and death. 6-Hydroxydopamine (6-OHDA) treatment markedly reduced, in a dose-response fashion, chromaffin cell viability. Cell death was accompanied by cell shrinkage, nuclear condensation and DNA degradation. Under our experimental conditions, 6-OHDA auto-oxidation formed quinones and reactive oxygen species (ROS) that mainly contributed to 6-OHDA-induced cytotoxicity in bovine chromaffin cells. Accordingly, different antioxidants, including catalase, vitamin E, Mn(IIItetrakis(4-benzoic acid)porphyrin chloride (MnTBAP) or ascorbic acid, provided protection against 6-OHDA-induced toxicity. Further evidence that 6-OHDA induces oxidative stress is provided by the fact that this compound decreased total mitochondrial reduced NAD(P)H levels. Our results also suggest that mitochondrial swelling and caspase activation do not play a direct role in 6-OHDA-induced death in bovine chromaffin cells.
引用
收藏
页码:1066 / 1073
页数:8
相关论文
共 50 条
  • [21] The effect of curcumin against 6-hydroxydopamine induced cell death and Akt/GSK disruption in human neuroblastoma cells
    Moosavi, Maryam
    Farrokhi, Majid Reza
    Tafreshi, Narges
    PHYSIOLOGY AND PHARMACOLOGY, 2018, 22 (03): : 163 - 171
  • [22] Mechanism of 6-hydroxydopamine neurotoxicity:: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons
    Rodriguez-Pallares, J.
    Parga, J. A.
    Munoz, A.
    Rey, P.
    Guerra, A. J.
    Labandeira-Garcia, J. L.
    JOURNAL OF NEUROCHEMISTRY, 2007, 103 (01) : 145 - 156
  • [23] PHARMACOLOGICAL PROTECTION AGAINST THE CYTOTOXICITY INDUCED BY 6-HYDROXYDOPAMINE AND H2O2 IN CHROMAFFIN CELLS
    ABAD, F
    MAROTO, R
    LOPEZ, MG
    SANCHEZGARCIA, P
    GARCIA, AG
    EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1995, 293 (01): : 55 - 64
  • [24] Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-κB) activation and cell death by tea extracts in neuronal cultures
    Levites, Y
    Youdim, MBH
    Maor, G
    Mandel, S
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (01) : 21 - 29
  • [25] Activation of NF-κB is involved in 6-hydroxydopamine -: but not MPP+-induced dopaminergic neuronal cell death:: its potential role as a survival determinant
    Park, SH
    Choi, WS
    Yoon, SY
    Ahn, YS
    Oh, YJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (03) : 727 - 733
  • [26] Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine
    Glinka, Y
    Tipton, KF
    Youdim, MBH
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (05) : 2004 - 2010
  • [27] Caspase activation and MPTP-induced cell death
    Nicotra, A
    Parvez, SH
    BIOGENIC AMINES, 2001, 16 (06) : 555 - 577
  • [28] Is the ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
    Lebsanft, HB
    Mayerhofer, A
    Kovar, KA
    Schmidt, WJ
    JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (07) : 707 - 718
  • [29] Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
    H. B. Lebsanft
    A. Mayerhofer
    K.-A. Kovar
    W. J. Schmidt
    Journal of Neural Transmission, 2003, 110 : 707 - 718
  • [30] POTENTIATION OF MORPHINE-INDUCED SEIZURE BY 6-HYDROXYDOPAMINE
    AYHAN, IH
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1976, 223 (02): : 282 - 286